Aylin Berwanger

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 3

Top Topics

Antimicrobial Resistance

Circulating Tumor

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Journal of medicinal chemistry

Future medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Aylin Berwanger, Saskia C Stein, Andreas Martin Kany, Melissa Gartner, Brigitta Loretz, Claus-Michael Lehr, Anna Katharina Herta Hirsch, Thomas F Schulz, Martin Empting
Disrupting Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Latent Replication with a Small Molecule Inhibitor. Journal of medicinal chemistry (2023)
Aylin Berwanger, Martin Empting
KSHV-specific antivirals targeting the protein-DNA interaction of the latency-associated nuclear antigen. Future medicinal chemistry 13 (13) (2021)
Christian Schütz, Duy-Khiet Ho, Mostafa Mohamed Hamed, Ahmed Saad Abdelsamie, Teresa Röhrig, Christian Herr, Andreas Martin Kany, Katharina Rox, Stefan Schmelz, Lorenz Siebenbürger, Marius Wirth, Carsten Börger, Samir Yahiaoui, Robert Bals, Andrea Scrima, Wulf Blankenfeldt, Justus Constantin Horstmann, Rebekka Christmann, Xabier Murgia, Marcus Koch, Aylin Berwanger, Brigitta Loretz, Anna Katharina Herta Hirsch, Rolf Wolfgang Hartmann, Claus-Michael Lehr, Martin Empting
A New PqsR Inverse Agonist Potentiates Tobramycin Efficacy to Eradicate Pseudomonas aeruginosa Biofilms. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (12) (2021)